(Q39438654)

12 September 2017

α-fetoprotein levels after interferon therapy and risk of hepatocarcinogenesis in chronic hepatitis C. (English)

1 reference

12 September 2017

1 reference

17

Mamoru Watanabe

1 reference

12 September 2017

18

Namiki Izumi

1 reference

12 September 2017

Yasuhiro Asahina

1

1 reference

12 September 2017

Kaoru Tsuchiya

2

1 reference

12 September 2017

Takashi Nishimura

3

1 reference

12 September 2017

Masaru Muraoka

4

1 reference

12 September 2017

Yuichiro Suzuki

5

1 reference

12 September 2017

Nobuharu Tamaki

6

1 reference

12 September 2017

Yutaka Yasui

7

1 reference

12 September 2017

Takanori Hosokawa

8

1 reference

12 September 2017

Ken Ueda

9

1 reference

12 September 2017

Hiroyuki Nakanishi

10

1 reference

12 September 2017

Jun Itakura

11

1 reference

12 September 2017

Yuka Takahashi

12

1 reference

12 September 2017

Masayuki Kurosaki

13

1 reference

12 September 2017

Nobuyuki Enomoto

14

1 reference

12 September 2017

Mina Nakagawa

15

1 reference

12 September 2017

Sei Kakinuma

16

1 reference

12 September 2017

language of work or name

English

0 references

publication date

19 August 2013

1 reference

12 September 2017

1 reference

12 September 2017

58

1 reference

12 September 2017

4

1 reference

12 September 2017

1253-1262

1 reference

12 September 2017

Hepatocellular carcinoma

1 reference

Global cancer statistics in the year 2000.

21 January 2018

1 reference

Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus

21 January 2018

1 reference

Effect of aging on risk for hepatocellular carcinoma in chronic hepatitis C virus infection

21 January 2018

1 reference

Relation of interferon therapy and hepatocellular carcinoma in patients with chronic hepatitis C. Osaka Hepatocellular Carcinoma Prevention Study Group

21 January 2018

1 reference

Effect of interferon therapy on hepatocellular carcinogenesis in patients with chronic hepatitis type C: A long-term observation study of 1,643 patients using statistical bias correction with proportional hazard analysis.

21 January 2018

1 reference

Interferon therapy reduces the risk for hepatocellular carcinoma: national surveillance program of cirrhotic and noncirrhotic patients with chronic hepatitis C in Japan. IHIT Study Group. Inhibition of Hepatocarcinogenesis by Interferon Therapy.

21 January 2018

1 reference

Sustained virological response to interferon-alpha is associated with improved outcome in HCV-related cirrhosis: a retrospective study

21 January 2018

1 reference

Alpha-fetoprotein levels in normal adults

21 January 2018

1 reference

Hepatocellular carcinoma: epidemiology, risk factors, and screening

21 January 2018

1 reference

Serum alpha-fetoprotein for diagnosis of hepatocellular carcinoma in patients with chronic liver disease: influence of HBsAg and anti-HCV status.

21 January 2018

1 reference

Racial differences in effectiveness of alpha-fetoprotein for diagnosis of hepatocellular carcinoma in hepatitis C virus cirrhosis

21 January 2018

1 reference

Elevations in serum alpha-fetoprotein levels in patients with chronic hepatitis B.

21 January 2018

1 reference

Serum alpha-fetoprotein levels in patients with chronic hepatitis C. Relationships with serum alanine aminotransferase values, histologic activity index, and hepatocyte MIB-1 scores

21 January 2018

1 reference

A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C.

21 January 2018

1 reference

Clinical and pathological factors associated with the development of hepatocellular carcinoma in patients with hepatitis virus-related cirrhosis: a long-term follow-up study.

21 January 2018

1 reference

Management of hepatocellular carcinoma

21 January 2018

1 reference

Hepatocyte proliferation and risk of hepatocellular carcinoma in cirrhotic patients.

21 January 2018

1 reference

Prediction model of hepatocarcinogenesis for patients with hepatitis C virus-related cirrhosis. Validation with internal and external cohorts

21 January 2018

1 reference

Clinical significance of elevated alpha-fetoprotein in Alaskan Native patients with chronic hepatitis C.

21 January 2018

1 reference

Alpha-fetoprotein above normal levels as a risk factor for the development of hepatocellular carcinoma in patients infected with hepatitis C virus

21 January 2018

1 reference

Serum alpha-fetoprotein levels in patients with advanced hepatitis C: results from the HALT-C Trial.

21 January 2018

1 reference

Decrease in alpha-fetoprotein levels predicts reduced incidence of hepatocellular carcinoma in patients with hepatitis C virus infection receiving interferon therapy: a single center study.

21 January 2018

1 reference

Clinical significance of elevated alpha-fetoprotein (AFP) in patients with chronic hepatitis C, but not hepatocellular carcinoma

21 January 2018

1 reference

Decreasing serum alpha-fetoprotein levels in predicting poor prognosis of acute hepatic failure in patients with chronic hepatitis B

21 January 2018

1 reference

Hepatitis C and Hepatocellular Carcinoma

21 January 2018

1 reference

7 January 2021

Alpha-fetoprotein changes in the course of chronic hepatitis: relation to bridging hepatic necrosis and hepatocellular carcinoma

1 reference

7 January 2021

Clinical, virologic, and pathologic significance of elevated serum alpha-fetoprotein levels in patients with chronic hepatitis C

1 reference

7 January 2021

Hepatocellular carcinoma in Italian patients with cirrhosis

1 reference

7 January 2021

Risk factors for hepatocellular carcinoma among patients with chronic liver disease

1 reference

7 January 2021

Prospective study of alpha-fetoprotein in cirrhotic patients monitored for development of hepatocellular carcinoma

1 reference

7 January 2021

Serum α-fetoprotein in fulminant hepatitis and hepatic regeneration following partial hepatectomy

1 reference

7 January 2021

Biomarkers of liver regeneration allow early prediction of hepatic recovery after acute necrosis

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEP.26442

1 reference

12 September 2017

1 reference